TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Feasibility and Effects of KOL-webben - an Internet Based Health Promotion Tool Directed Towards People With Chronic Obstructive Pulmonary Disease and Staff in the Primary Health Care in Sweden
Brief Summary: This study evaluates the effects of KOL-webben (the COPD web), an interactive web-based system directed towards two target groups; people with chronic obstructive pulmonary disease (COPD) and health professionals in primary care. KOL-webben include tools that improve health literacy with a specific focus on 1) increased physical activity and 2) use of appropriate self-management strategies. Moreover, KOL-webben include knowledge and tools directed towards staff in the primary care aimed to implement provision of evidence based health promotion interventions.The feasibility and effects of KOL-webben will be evaluated.


Options:
A: Arm Label: KOLwebben; Type: EXPERIMENTAL; Interventions: Behavioral: KOLwebben | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: KOLwebben; Assigned to Arm(s): KOLwebben
B: Arm Label: Pulmonary Rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary Rehabilitation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pulmonary Rehabilitation; Assigned to Arm(s): Pulmonary Rehabilitation
C: Arm Label: Home-base Pulm Rehab w/ Health Coaching; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home-base Pulmonary Rehab with Health Coaching | Arm Label: Control/Wait; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home-base Pulmonary Rehab with Health Coaching | Intervention Type: BEHAVIORAL; Name: Home-base Pulmonary Rehab with Health Coaching; Assigned to Arm(s): Control/Wait, Home-base Pulm Rehab w/ Health Coaching
D: Arm Label: MOBILE-A; Type: EXPERIMENTAL; Interventions: Behavioral: Coached exercise persistence intervention | Arm Label: MOBILE-B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-Monitored exercise persistence intervention | Intervention Type: BEHAVIORAL; Name: Coached exercise persistence intervention; Assigned to Arm(s): MOBILE-A | Intervention Type: BEHAVIORAL; Name: Self-Monitored exercise persistence intervention; Assigned to Arm(s): MOBILE-B

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Feasibility and Effects of KOL-webben - an Internet Based Health Promotion Tool Directed Towards People With Chronic Obstructive Pulmonary Disease and Staff in the Primary Health Care in Sweden
Brief Summary: This study evaluates the effects of KOL-webben (the COPD web), an interactive web-based system directed towards two target groups; people with chronic obstructive pulmonary disease (COPD) and health professionals in primary care. KOL-webben include tools that improve health literacy with a specific focus on 1) increased physical activity and 2) use of appropriate self-management strategies. Moreover, KOL-webben include knowledge and tools directed towards staff in the primary care aimed to implement provision of evidence based health promotion interventions.The feasibility and effects of KOL-webben will be evaluated.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Tele rehab | Intervention Type: BEHAVIORAL; Name: Tele rehab; Assigned to Arm(s): Intervention group
B: Arm Label: Remote-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with remote-monitoring | Arm Label: Self-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with self-monitoring | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cloud Dx Kit with self-monitoring; Assigned to Arm(s): Self-Monitoring Program | Intervention Type: DEVICE; Name: Cloud Dx Kit with remote-monitoring; Assigned to Arm(s): Remote-Monitoring Program
C: Arm Label: Hospital-based; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary rehabilitation (teaching and exercise) | Arm Label: Home-Based; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Pulmonary rehabilitation (teaching and exercise) | Intervention Type: BEHAVIORAL; Name: Pulmonary rehabilitation (teaching and exercise); Assigned to Arm(s): Home-Based, Hospital-based
D: Arm Label: KOLwebben; Type: EXPERIMENTAL; Interventions: Behavioral: KOLwebben | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: KOLwebben; Assigned to Arm(s): KOLwebben

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Feasibility and Effects of KOL-webben - an Internet Based Health Promotion Tool Directed Towards People With Chronic Obstructive Pulmonary Disease and Staff in the Primary Health Care in Sweden
Brief Summary: This study evaluates the effects of KOL-webben (the COPD web), an interactive web-based system directed towards two target groups; people with chronic obstructive pulmonary disease (COPD) and health professionals in primary care. KOL-webben include tools that improve health literacy with a specific focus on 1) increased physical activity and 2) use of appropriate self-management strategies. Moreover, KOL-webben include knowledge and tools directed towards staff in the primary care aimed to implement provision of evidence based health promotion interventions.The feasibility and effects of KOL-webben will be evaluated.


Options:
A: Arm Label: Disease management program; Type: EXPERIMENTAL; Interventions: Other: Disease Management | Arm Label: Usual site management; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual site management | Intervention Type: OTHER; Name: Disease Management; Assigned to Arm(s): Disease management program | Intervention Type: OTHER; Name: Usual site management; Assigned to Arm(s): Usual site management
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: pulmonary outpatient rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: pulmonary outpatient rehabilitation | Intervention Type: PROCEDURE; Name: pulmonary outpatient rehabilitation; Assigned to Arm(s): pulmonary outpatient rehabilitation
C: Arm Label: Group A, Telerehabilitation; Type: EXPERIMENTAL; Interventions: Other: Telerehabilitation | Arm Label: Group B, Hospital based Rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Other: Hospital based Rehabilitation | Arm Label: Group C, Usual care Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telerehabilitation; Assigned to Arm(s): Group A, Telerehabilitation | Intervention Type: OTHER; Name: Hospital based Rehabilitation; Assigned to Arm(s): Group B, Hospital based Rehabilitation
D: Arm Label: KOLwebben; Type: EXPERIMENTAL; Interventions: Behavioral: KOLwebben | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: KOLwebben; Assigned to Arm(s): KOLwebben

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hummus for Health: Dietary Quality and Health Outcomes in Toddlers
Brief Summary: The goal of this study is to examine the effect of increasing children's intake of fiber and unsaturated fat, through daily servings of hummus and vegetables, on their microbiome profile.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group
B: Arm Label: Hummus and vegetables; Type: EXPERIMENTAL; Interventions: Other: Lesson about vegetables, Other: Vegetables, Other: Hummus | Arm Label: Vegetables only; Type: EXPERIMENTAL; Interventions: Other: Lesson about vegetables, Other: Vegetables | Intervention Type: OTHER; Name: Lesson about vegetables; Assigned to Arm(s): Hummus and vegetables, Vegetables only | Intervention Type: OTHER; Name: Vegetables; Assigned to Arm(s): Hummus and vegetables, Vegetables only | Intervention Type: OTHER; Name: Hummus; Assigned to Arm(s): Hummus and vegetables
C: Arm Label: Cucumber; Type: EXPERIMENTAL; Interventions: Other: Cucumber snack | Arm Label: Pepper; Type: EXPERIMENTAL; Interventions: Other: Pepper snack | Arm Label: Tomato; Type: EXPERIMENTAL; Interventions: Other: Tomato snack | Arm Label: Vegetable variety; Type: EXPERIMENTAL; Interventions: Other: Vegetable variety snack | Arm Label: Apple; Type: EXPERIMENTAL; Interventions: Other: Apple snack | Arm Label: Peach; Type: EXPERIMENTAL; Interventions: Other: Peach snack | Arm Label: Pineapple; Type: EXPERIMENTAL; Interventions: Other: Pineapple snack | Arm Label: Fruit variety; Type: EXPERIMENTAL; Interventions: Other: Fruit variety snack | Intervention Type: OTHER; Name: Cucumber snack; Assigned to Arm(s): Cucumber | Intervention Type: OTHER; Name: Pepper snack; Assigned to Arm(s): Pepper | Intervention Type: OTHER; Name: Tomato snack; Assigned to Arm(s): Tomato | Intervention Type: OTHER; Name: Vegetable variety snack; Assigned to Arm(s): Vegetable variety | Intervention Type: OTHER; Name: Apple snack; Assigned to Arm(s): Apple | Intervention Type: OTHER; Name: Peach snack; Assigned to Arm(s): Peach | Intervention Type: OTHER; Name: Pineapple snack; Assigned to Arm(s): Pineapple | Intervention Type: OTHER; Name: Fruit variety snack; Assigned to Arm(s): Fruit variety
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 3

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hummus for Health: Dietary Quality and Health Outcomes in Toddlers
Brief Summary: The goal of this study is to examine the effect of increasing children's intake of fiber and unsaturated fat, through daily servings of hummus and vegetables, on their microbiome profile.


Options:
A: Arm Label: Hummus and vegetables; Type: EXPERIMENTAL; Interventions: Other: Lesson about vegetables, Other: Vegetables, Other: Hummus | Arm Label: Vegetables only; Type: EXPERIMENTAL; Interventions: Other: Lesson about vegetables, Other: Vegetables | Intervention Type: OTHER; Name: Lesson about vegetables; Assigned to Arm(s): Hummus and vegetables, Vegetables only | Intervention Type: OTHER; Name: Vegetables; Assigned to Arm(s): Hummus and vegetables, Vegetables only | Intervention Type: OTHER; Name: Hummus; Assigned to Arm(s): Hummus and vegetables
B: Arm Label: waitlist control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Movie Models | Intervention Type: BEHAVIORAL; Name: Movie Models; Assigned to Arm(s): intervention group
C: Arm Label: Immediate Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Eating and Physical Activity | Arm Label: Delayed Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Eating and Physical Activity | Intervention Type: BEHAVIORAL; Name: Healthy Eating and Physical Activity; Assigned to Arm(s): Delayed Intervention, Immediate Intervention
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Advice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants
Brief Summary: Two innovative approaches, pulsatile orocutaneous entrainment of non-nutritive suck via orosensory entrainment (NTrainer) device technology and serial salivary gene expression analyses, will be merged to examine the relation between gene expression, oral somatosensory stimulation, feeding behavior, and neurodevelopmental outcomes at 18 months corrected age (CA) on 180 extremely preterm infants \[EPIs\] (24 0/7-26 6/7 GA and 27 0/7 - 28 6/7 GA) enrolled at three neonatal intensive care units: Catholic Health Initiative (CHI) Health St. Elizabeth (Lincoln, NE), Tufts Medical Center (Boston, MA), and Santa Clara Valley Medical Center (San Jose, CA). EPIs will be randomized to a blind pacifier (SHAM) or PULSED NTrainer treatment groups, and stratified by GA, sex, and bronchopulmonary dysplasia status (BPD vs non-BPD). We hypothesize that the combination of the NTrainer® intervention for improved oral feeding skills, along with objective salivary gene expression data to monitor response to treatment and feeding development, will result in a novel, objective, and personalized approach to neonatal oral feeding and reduce the duration of time to attain oral feeds while improving feeding, growth and neurodevelopmental outcomes at 18 months' CA.


Options:
A: Intervention Type: DEVICE; Name: partial-vacuum milk bottle; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: anti-vacuum milk bottle; Assigned to Arm(s): N/A
B: Arm Label: EPI experimental; Type: EXPERIMENTAL; Interventions: Device: NTrainer | Arm Label: EPI control; Type: SHAM_COMPARATOR; Interventions: Device: SHAM blind pacifier | Intervention Type: DEVICE; Name: NTrainer; Assigned to Arm(s): EPI experimental | Intervention Type: DEVICE; Name: SHAM blind pacifier; Assigned to Arm(s): EPI control
C: Arm Label: NTrainer® Intervention; Type: EXPERIMENTAL; Interventions: Device: NTrainer® Intervention | Arm Label: Control Intervention; Type: SHAM_COMPARATOR; Interventions: Device: Control Intervention | Intervention Type: DEVICE; Name: NTrainer® Intervention; Assigned to Arm(s): NTrainer® Intervention | Intervention Type: DEVICE; Name: Control Intervention; Assigned to Arm(s): Control Intervention
D: Arm Label: skin to skin contact; Type: EXPERIMENTAL; Interventions: Other: skin to skin contact | Arm Label: Control group; Type: EXPERIMENTAL; Interventions: Other: Control group | Intervention Type: OTHER; Name: skin to skin contact; Assigned to Arm(s): skin to skin contact | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Control group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Brief Summary: This is a randomized, double blind, placebo-controlled, parallel-arm, multi-center, Phase 2, proof-of-concept efficacy and safety study in patients with end-stage renal disease requiring hemodialysis.

The purpose of the study is to determine the efficacy and safety profile of PA101B delivered via eFlow high efficiency nebulizer in patients with uremic pruritus who are symptomatic despite using standard treatments.


Options:
A: Arm Label: PA101B; Type: EXPERIMENTAL; Interventions: Drug: PA101B | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: PA101B; Assigned to Arm(s): PA101B | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Senna; Type: ACTIVE_COMPARATOR; Interventions: Drug: Senna | Intervention Type: DRUG; Name: Senna; Assigned to Arm(s): Senna | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: nalbuphine HCl ER 60mg; Type: EXPERIMENTAL; Interventions: Drug: nalbuphine HCl ER tablets 60 mg BID | Arm Label: nalbuphine HCl ER 120mg; Type: EXPERIMENTAL; Interventions: Drug: nalbuphine HCl ER tablets 120mg BID | Arm Label: Sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tablets BID | Intervention Type: DRUG; Name: nalbuphine HCl ER tablets 60 mg BID; Assigned to Arm(s): nalbuphine HCl ER 60mg | Intervention Type: DRUG; Name: nalbuphine HCl ER tablets 120mg BID; Assigned to Arm(s): nalbuphine HCl ER 120mg | Intervention Type: DRUG; Name: Placebo tablets BID; Assigned to Arm(s): Sugar pill
D: Arm Label: Wheat; Type: PLACEBO_COMPARATOR; Interventions: Drug: Wheat | Arm Label: Fumaria; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fumaria | Intervention Type: DRUG; Name: Wheat; Assigned to Arm(s): Wheat | Intervention Type: DRUG; Name: Fumaria; Assigned to Arm(s): Fumaria

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Intrauterine growth restriction is a common and complex obstetric problem. Intrauterine growth restriction is noted to affect approximately 10-15 % of pregnant women. Intrauterine growth restriction is diagnosed antenatal; however, some of these fetuses, especially if unscreened during pregnancy, may be detected only in the neonatal period. It is very important for obstetricians and perinatologists to identify growth restricted fetuses, because this fetal condition is associated with significant perinatal morbidity and mortality.

Omega 3 is composed of polyunsaturated fatty acids with a double bond at the third carbon atom from the end of the carbon chain. The fatty acids have two ends, the carboxylic acid end, which is considered the beginning of the chain, thus "alpha", and the methyl end, which is considered the "tail" of the chain, thus "omega." Omega3 improve fetal wellbeing by two mechanisms: Firstly, maternal and docosahexaenoic acid supplementation during pregnancy and lactation normalizes intrauterine growth restriction induced changes in adipose deposition and visceral PPARγ expression. Secondly, maternal docosahexaenoic acid supplementation increases serum adiponectin, as well as adipose expression of adiponectin and adiponectin receptors. Novel findings suggest that maternal docosahexaenoic acid supplementation normalize adipose dysfunction and promote adiponectin-induced improvements in metabolic function in intrauterine growth restriction


Options:
A: Arm Label: Low dose aspirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Low dose aspirin | Arm Label: Low dose aspirin plus omega 3 group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Low dose aspirin, Drug: Omega 3 | Intervention Type: DRUG; Name: Low dose aspirin; Assigned to Arm(s): Low dose aspirin, Low dose aspirin plus omega 3 group | Intervention Type: DRUG; Name: Omega 3; Assigned to Arm(s): Low dose aspirin plus omega 3 group
B: Arm Label: Dietary advice and grocery store card; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary advice | Arm Label: Dietary advice; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary advice | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Dietary advice; Assigned to Arm(s): Dietary advice, Dietary advice and grocery store card | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control
C: Arm Label: Observational; Type: N/A; Interventions: N/A
D: Arm Label: 1; Type: OTHER; Interventions: Dietary Supplement: omega 3 fatty acids | Arm Label: 2; Type: OTHER; Interventions: Dietary Supplement: vegetable oil | Intervention Type: DIETARY_SUPPLEMENT; Name: omega 3 fatty acids; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: vegetable oil; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South Africa
Brief Summary: The purpose of this study is to conduct a two-arm effectiveness trial in Cape Town, South Africa of a Xhosa-adapted, nurse-delivered, cognitive behavioral therapy (CBT) treatment for depression and adherence, integrated into the HIV care setting in patients with HIV who did not achieve viral suppression from first-line treatment. The CBT treatment will be compared to enhanced usual care (Enhanced Treatment As Usual - ETAU) on study endpoints (as described in study endpoints section below).


Options:
A: Arm Label: Cognitive Behavioral Therapy Intervention for Anxiety; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy Intervention for Anxiety; Assigned to Arm(s): Cognitive Behavioral Therapy Intervention for Anxiety
B: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: PC101+Mental Health | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PC101+Mental Health | Intervention Type: BEHAVIORAL; Name: PC101+Mental Health; Assigned to Arm(s): Control, Intervention
C: Arm Label: THPP+; Type: EXPERIMENTAL; Interventions: Behavioral: Thinking Healthy Program Peer Delivered Plus | Arm Label: Enhanced Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Thinking Healthy Program Peer Delivered Plus; Assigned to Arm(s): THPP+ | Intervention Type: OTHER; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care
D: Arm Label: CBT-AD; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy for Adherence and Depression | Arm Label: ETAU; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for Adherence and Depression; Assigned to Arm(s): CBT-AD

Answer: D